all report title image
  • Published On : Sep 2020
  • Code : CMI4165
  • Industry : Medical Devices
  • Pages : 123
  • Formats :

The increasing healthcare expenditure and adaptability of demand for minimally invasive surgery are expected to fuel growth of angiostomy cannula market over the forecast period. According to data of the U.S. Centers for Medicare & Medicaid, the U.S. healthcare expenditure grew by 4.6%, which is around US$ 3.6 trillion in 2018. The high government expenditure and support for treatment of various diseases will provide huge reimbursement opportunity for medical device manufacturers such as angiostomy cannula. Moreover, advancement in technology made cannulas with improved features have made surgical procedure duration shorter and it also helps in faster recovery of patients. The increasing availability of such devices is expected to fuel the global angiostomy cannula market growth.

Global Angiostomy Cannula Market - Impact of Coronavirus (Covid-19) Pandemic

The spread of coronavirus has negatively impacted the global angiostomy cannula market. The outbreak of this virus has hindered growth of the global market. The U.S has the highest number of corona patients, which is expected to impact the country’s economic condition and government healthcare spending. Similarly, the countries such as Italy, Spain, Russia, India, Brazil, and many other economies are also suffering from Covid-19 attack, which is expected to negatively impact the Global Angiostomy Cannula Market growth. Furthermore, due to COVID-19 pandemic, hospitals are closed in containment zones, which has resulted in decline in sales of medical devices such as angiostomy cannula.

The global angiostomy cannula market is estimated to be valued at US$ 136.5 Mn in 2020 and is expected to exhibit a CAGR of 6.9% during the forecast period (2020-2027).

Figure 1: Global Angiostomy Cannula Market Share (%) Analysis, By Product Type

Angiostomy Cannula  | Coherent Market Insights

Global Angiostomy Cannula Market - Restraints

The stringent government regulations is a major factor restraining growth of the global angiostomy cannula market. Key players in the market are facing product recalls, which is expected to restrain the market growth. For instance, in 2019, the U.S FDA terminated BVI Visitec Soft Tip Cannula, a product of the U.S.-based Beaver Visitec Company. The reason for recall of this product was that protective sheath component over the silicone tip was missing in few lots of cannula detaching at the metal tube component. This could cause eye injury during surgical procedure.

Similarly, in 2019, Health Canada recalled QuickDraw 22 & 25 Venous Cannula product of Edwards Lifesciences LLC. The reason for recall was that Edwards Lifesciences LLC identified safety risk that may occur during the use of QuickDraw Venous Cannula models QD22 and QD25 when used in an unintended manner.

CMI table icon

Angiostomy Cannula Market Report Coverage

Report Coverage Details
Base Year: 2019 Market Size in 2019: US$ 136.5 Mn
Historical Data for: 2016 to 2019 Forecast Period: 2020 to 2027
Forecast Period 2020 to 2027 CAGR: 6.9% 2027 Value Projection: US$ 218.5 Mn
Geographies covered:
  • North America: U.S. and Canada
  • Latin America: Brazil, Argentina, Mexico, and Rest of Latin America
  • Europe: Germany, U.K., Spain, France, Italy, Russia, and Rest of Europe
  • Asia Pacific: China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific
  • Middle East: GCC, Israel, and Rest of Middle East
  • Africa: South Africa, North Africa, and Central Africa
Segments covered:
  • By Type: Cardiac cannula, Vascular cannula, Arthroscopy cannula, Dermatology cannula, Nasal cannula, Floating spinal cannulas, Vitreoretinal cannulas, Hysterosalpingography cannulas.
  • By Application: Cardiovascular Surgery, Oxygen Therapy, Orthopedic Surgery, Diabetes treatment, Neurology, General Surgery, Cosmetic/Plastic Surgery.
  • By End User: Hospitals, Ambulatory Surgical Centers, Blood Banks, Home Healthcare Facilities.
Companies covered:

Smith & Nephew, Maquet Holding B.V. & Co. KG., Sorin Group, Edward Lifescience Corporation, Medtronic plc, Terumo Corporation, Medline Industries, Inc., Cardinal Health, Boston Scientific Corporation, Teleflex Incorporated, Conmed Corporation, Dolphin Surgicals, Micromed International, Goodhealth Inc., and BioTek Instruments, Inc.

Growth Drivers:
  • Rise in general surgical procedures and increase in geriatric population across the globe
Restraints & Challenges:
  • Increasing product recalls

Global Angiostomy Cannula Market: Opportunities

Increasing funding for hospital services is expected to offer lucrative growth opportunities for players in the global angiostomy cannula market. For instance, in August 2019, according to Australian Institute of Health and Welfare’s Hospitals at a glance 2017–18 report updated in August 2019, funding for hospital services increased between 2016-2017 and 2017-2018 by 1.8% per year on an average in public hospitals and by 2.9% per year on an average in private hospitals in Australia.

Global Angiostomy Cannula Market – Regional Analysis

On the basis of region, the global angiostomy cannula market is segmented into North America, Latin America, Europe, Asia Pacific, Middle East, and Africa.

The North America is expected to contribute major market share, followed by Asia Pacific, owing to the rising rate of geriatric population due to increase in population size, increasing number of patients undergoing various surgical procedures, and increasing change in lifestyle related diseases such as obesity. For instance, according to Population Reference Bureau of the U.S data 2018, In the U.S the number of people aged 65 and older were 52 million in 2018 and it is projected to nearly double around 95 million by 2060. The expected rise of 65-and-older age group’s share of the total population will be from 16% to 23%. Such high number of increasing geriatric population will increase the number of surgeries in the near future. Angiostomy cannulas are used in healthcare for surgical use, which is a major factor driving growth of the global angiostomy cannula market.

Figure 2 : Global Angiostomy Cannula Market Value (US$ Mn) & Y-o-Y Growth (%), 2017-2027

Angiostomy Cannula  | Coherent Market Insights

Global Angiostomy Cannula Market - Competitive Landscape

Key players operating in the global angiostomy cannula market include Smith & Nephew, Maquet Holding B.V. & Co. KG., Sorin Group, Edward Lifescience Corporation, Medtronic plc, Terumo Corporation, Medline Industries, Inc., Cardinal Health, Boston Scientific Corporation, Teleflex Incorporated, Conmed Corporation, Dolphin Surgicals, Micromed International, Goodhealth Inc., and BioTek Instruments, Inc.

Angiostomy cannula is a thin tube, which is inserted into the human body veins or body cavity to introduce medication, removal of fluid or to insert a surgical instrument. Cannula is usually surrounded by the trocar needle with inner and outer surface, which allows puncturing of the body in order to get enough space. It is also known as intravenous IV cannula. The normal cannula size mainly ranges around 14 – 24 gauge.

There are various types of cannula such as venous cannula, arterial cannula, nasal cannula or an oral-nasal cannula. The venous cannula is used for inserting in veins for the removal of blood samples and for administering medicines. An arterial cannula is used to insert in the artery of human body, commonly in the radial artery, during major operations such as bypass surgery and are also used to measure beat to beat blood pressure, which is a painful procedure that leads to stress and anxiety. The nasal cannula or the oral nasal cannula is used to insert into nostrils and mouth, and also for delivering oxygen or to measure the airflow into the nose.

On the basis of size, it is differentiated into colours such as orange (14G), grey (16G), green (18G), pink (20G), blue (22G), yellow (24G), and violet (26G). The use of these various sizes of cannula depends on the patient’s age, physique, and the application of the cannula. The materials that are used to make cannulas are plastic, metal, and silicon, as the silicon material is expected to support growth of the cannula market, as this type of cannula is more flexible and soft to use.

Market Dynamics

The increasing geriatric population across the globe is expected to drive growth of the global angiostomy cannula market. According to World Population Aging 2019 report published by United Nations, globally, the share of aging population who are 65 years old and above grew by 6% between 1990 and 2019. The current population of this age group is around 703 million and is projected to reach around 1.5 billion in 2050. The high projected growth of geriatric population will increase the number of surgeries that will contribute to growth of the angiostomy cannula market.

Key features of the study:

  • This report provides in-depth analysis of the global angiostomy cannula market, market size (US$ Mn), and compound annual growth rate (CAGR (%)) for the forecast period: 2020-2027, considering 2019 as the base year.
  • It elucidates potential revenue opportunity across different segments and explains attractive investment proposition matrix for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by leading players.
  • It profiles key players in the global angiostomy cannula market, based on the following parameters – company overview, financial performance, product portfolio, geographical presence, distribution strategies, key developments, and strategies.
  • Key players covered as a part of this study include Smith & Nephew, Maquet Holding B.V. & Co. KG., Sorin Group, Edward Lifescience Corporation, Medtronic plc, Terumo Corporation, Medline Industries, Inc., Cardinal Health, Boston Scientific Corporation, Teleflex Incorporated, Conmed Corporation, Dolphin Surgicals, Micromed International, Goodhealth Inc., and BioTek Instruments, Inc.
  • Insights from this report would allow marketers and management authorities of companies to make informed decisions with respect to future product launches, governmental initiatives, technological up-gradation, market expansion, and marketing tactics
  • The global angiostomy cannula market report caters to various stakeholders in this industry, including investors, product manufacturers, distributors, and suppliers for global angiostomy cannula market, research and consulting firms, new entrants, and financial analysts.

Detailed Segmentation:

  • Global Angiostomy Cannula Market, By Type:
    • Cardiac cannula
    • Vascular cannula
    • Arthroscopy cannula
    • Dermatology cannula
    • Nasal cannula
    • Floating spinal cannula
    • Vitreoretinal cannula
    • Hysterosalpingography cannula
  • Global Angiostomy Cannula Market, By Application:
    • Cardiovascular Surgery
    • Oxygen Therapy
    • Orthopedic Surgery
    • Diabetes treatment
    • Neurology
    • General Surgery
    • Cosmetic/Plastic Surgery
  • Global Angiostomy Cannula Market, By End User:
    • Hospitals
    • Ambulatory Surgical Centers
    • Blood Banks
    • Home Healthcare Facilities
  • Global Angiostomy Cannula Market, By Region:
    • North America
      • By Country:
        • U.S.
        • Canada
      • By Type:
        • Cardiac cannula
        • Vascular cannula
        • Arthroscopy cannula
        • Dermatology cannula
        • Nasal cannula
        • Floating spinal cannulas
        • Vitreoretinal cannulas
        • Hysterosalpingography cannulas
      • By Application
        • Cardiovascular Surgery
        • Oxygen Therapy
        • Orthopedic Surgery
        • Diabetes treatment
        • Neurology
        • General Surgery
        • Cosmetic/Plastic Surgery
      • By End User :
        • Hospitals
        • Ambulatory Surgical Centers
        • Blood Banks
        • Home Healthcare Facilities
    • Europe
      • By Country:
        • U.K.
        • Germany
        • Italy
        • Spain
        • France
        • Russia
        • Rest of Europe
      • By Type:
        • Cardiac cannula
        • Vascular cannula
        • Arthroscopy cannula
        • Dermatology cannula
        • Nasal cannula
        • Floating spinal cannulas
        • Vitreoretinal cannulas
        • Hysterosalpingography cannulas
      • By Application
        • Cardiovascular Surgery
        • Oxygen Therapy
        • Orthopedic Surgery
        • Diabetes treatment
        • Neurology
        • General Surgery
        • Cosmetic/Plastic Surgery
      • By End User :
        • Hospitals
        • Ambulatory Surgical Centers
        • Blood Banks
        • Home Healthcare Facilities
    • Asia Pacific
      • By Country:
        • Australia
        • India
        • China
        • Japan
        • ASEAN
        • South Korea
        • Rest of Asia Pacific
      • By Type:
        • Cardiac cannula
        • Vascular cannula
        • Arthroscopy cannula
        • Dermatology cannula
        • Nasal cannula
        • Floating spinal cannulas
        • Vitreoretinal cannulas
        • Hysterosalpingography cannulas
      • By Application
        • Cardiovascular Surgery
        • Oxygen Therapy
        • Orthopedic Surgery
        • Diabetes treatment
        • Neurology
        • General Surgery
        • Cosmetic/Plastic Surgery
      • By End User :
        • Hospitals
        • Ambulatory Surgical Centers
        • Blood Banks
        • Home Healthcare Facilities
    • Latin America
      • By Country:
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
      • By Type:
        • Cardiac cannula
        • Vascular cannula
        • Arthroscopy cannula
        • Dermatology cannula
        • Nasal cannula
        • Floating spinal cannulas
        • Vitreoretinal cannulas
        • Hysterosalpingography cannulas
      • By Application
        • Cardiovascular Surgery
        • Oxygen Therapy
        • Orthopedic Surgery
        • Diabetes treatment
        • Neurology
        • General Surgery
        • Cosmetic/Plastic Surgery
      • By End User :
        • Hospitals
        • Ambulatory Surgical Centers
        • Blood Banks
        • Home Healthcare Facilities
    • Middle East
      • By Country:
        • GCC
        • Israel
        • Rest of Middle East
      • By Type:
        • Cardiac cannula
        • Vascular cannula
        • Arthroscopy cannula
        • Dermatology cannula
        • Nasal cannula
        • Floating spinal cannulas
        • Vitreoretinal cannulas
        • Hysterosalpingography cannulas
      • By Application
        • Cardiovascular Surgery
        • Oxygen Therapy
        • Orthopedic Surgery
        • Diabetes treatment
        • Neurology
        • General Surgery
        • Cosmetic/Plastic Surgery
      • By End User :
        • Hospitals
        • Ambulatory Surgical Centers
        • Blood Banks
        • Home Healthcare Facilities
    • Africa
      • By Country/Region:
        • South Africa
        • Central Africa
        • North Africa
      • By Type:
        • Cardiac cannula
        • Vascular cannula
        • Arthroscopy cannula
        • Dermatology cannula
        • Nasal cannula
        • Floating spinal cannulas
        • Vitreoretinal cannulas
        • Hysterosalpingography cannulas
      • By Application
        • Cardiovascular Surgery
        • Oxygen Therapy
        • Orthopedic Surgery
        • Diabetes treatment
        • Neurology
        • General Surgery
        • Cosmetic/Plastic Surgery
      • By End User :
        • Hospitals
        • Ambulatory Surgical Centers
        • Blood Banks
        • Home Healthcare Facilities
  • Company Profiles
    • Smith & Nephew*
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Recent Highlights
      • Strategies
    • Maquet Holding B.V. & Co. KG.
    • Sorin Group
    • Edward Lifescience Corporation
    • Medtronic plc
    • Terumo Corporation
    • Medline Industries, Inc.
    • Cardinal Health,
    • Boston Scientific Corporation
    • Teleflex Incorporated
    • Conmed Corporation
    • Dolphin Surgicals
    • Micromed International
    • Goodhealth Inc.
    • BioTek Instruments, Inc.

“*” marked represents similar segmentation in other categories in the respective section.

Frequently Asked Questions

The global angiostomy cannula market is expected to register a CAGR of 6.9% during the forecast period (2020-2027).
The market value of the global angiostomy cannula market is estimated to be US$ 136.5 million in 2020.
The prominent players in the global angiostomy cannula market include Smith & Nephew, Maquet Holding B.V. & Co. KG., Sorin Group, Edward Lifescience Corporation, Medtronic plc, Terumo Corporation, Medline Industries, Inc., Cardinal Health, Boston Scientific Corporation, Teleflex Incorporated, Conmed Corporation, Dolphin Surgicals, Micromed International, Goodhealth Inc., and BioTek Instruments, Inc.
The angiostomy cannula market is expected to be valued at US$ 218.5 million in 2027.
North America is a major region in the global angiostomy cannula market.
Approval and launch of novel therapies for performing different surgical procedures is expected to propel growth of the global angiostomy cannula market during the forecast period. Moreover, companies are focused on research and development to address the unmet needs of the market, which is expected to drive the global angiostomy cannula market growth.

Related Reports

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo